Narlin Beaty, MD
Neurological Surgery · Tallahassee, FLNPI 1184859530
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $313,136 of the $423,029 with a category attached, or 74.0%. Stryker accounts for 87.6% of it on its own, with 54 other manufacturers making up the rest. Reporting peaked in 2021 at $136,805 and has fallen 90.8% since, to $12,624 in 2025. Among neurological surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 588 payments — averaging $719.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$371K
- AstraZeneca$47K
- Medtronic$2K
- Imperative Care, Inc$749
- Johnson & Johnson$393
- Ulrich Medical USA, Inc.$190
- plus $2K from 49 others
Across 6 payments — averaging $8130.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tanabe Pharma America, Inc.$46K
- Imperative Care, Inc$3K
What the payments were for
- Consulting fees$313,13674%
- Speaking & faculty fees$39,4909%
- Travel & lodging$62,49615%
- Food & beverage$7,8602%
- Education$320%
- Ownership interest$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SURPASS EVOLVE$223,048
- SURPASS$124,838
- ANDEXXA$46,733
- 1488, IDEAL EYES$14,700
- UNIVERSAL NEURO 3$2,419
- CD HORIZON$1,094
- NEURO$712
- TARGET$581
- PROCUITY$483
- TREVO$201
- INFINITY$145
- CATALYST$145
How this compares
$423,029 in reported general payments places this provider in the 95th percentile of 556 neurological surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 32 | $607 |
| Celecoxib | 13 | $466 |
| ClopidogrelClopidogrel Bisulfate | 36 | $341 |
| Levetiracetam | 12 | $299 |
| Methocarbamol | 11 | $174 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $164 |
| Methylprednisolone | 14 | $110 |
| Tramadol Hcl | 18 | $94 |
| Oxycodone Hcl | 13 | $91 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Tallahassee
- Griffin BaumTallahassee$494K
- Stephen ParkerJacksonville$18.7M
- Eric PetersonMiami$10.1M
- Brian SnellingBoca Raton$10M
- Kim ManwaringOrlando$5M
- Paul SawinWinter Park$3M
- John MainOcala$2.8M
- Michael WangMiami$2.2M
- Andrew CannestraJacksonville$1.6M
- Rohit VasanTampa$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.